<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rat bite fever</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rat bite fever</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Rat bite fever</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Katherine Yudeh King, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 31, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Rat bite fever (RBF) is a rarely diagnosed, systemic illness caused by infection with <em>Streptobacillus moniliformis, Streptobacillus notomytis</em>, or <em>Spirillum minus</em>. This topic will review the clinical manifestations, diagnosis, and treatment of patients with RBF. The topic that discusses the management of animal bites is presented separately. (See  <a class="medical medical_review" href="/z/d/html/7671.html" rel="external">"Animal bites (dogs, cats, and other mammals): Evaluation and management"</a>.) </p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>In the United States, RBF is typically caused by <em>S. moniliformis</em>. The disease is rare, with only several cases documented each year. As an example, between 2000 and 2012, only 17 cases were identified in California [<a href="#rid1">1</a>]. However, its actual incidence is unknown because RBF is not a nationally notifiable disease, and many cases go undiagnosed since these bacteria are difficult to identify and are likely to respond to empiric antibiotic therapy. (See <a class="local">'Treatment'</a> below.) </p><p>The risk of RBF due to <em>S. moniliformis</em> after a rat bite is reported to be 10 percent [<a href="#rid2">2</a>], and an estimated 20,000 rat bites occur in the United States each year [<a href="#rid2">2</a>]. Historically, over 50 percent of reported cases occurred in children, and RBF was most likely to be seen in those living in poverty [<a href="#rid3">3</a>]. However, the demographics have changed to include pet store workers and laboratory technicians as rats have become popular pets and research subjects [<a href="#rid4">4,5</a>]. A nation-wide survey in the United States found that 0.33 in one million persons visited the emergency department for rat bite fever and 0.20 in one million were hospitalized; the true incidence of rat bite fever in the United States is probably even lower because this study utilized coding data to identify cases and did not require microbiologic confirmation of the illness [<a href="#rid6">6</a>]. </p><p>In Asia, RBF is known as sodoku (<em>so</em>: rat; and <em>doku</em>: poison) and it is primarily caused by <em>S. minus </em>[<a href="#rid2">2</a>]. <em>S. notomytis</em> has also been reported in Japan. This species was originally isolated from a spinifex hopping mouse in 1979 and was described genetically in 2015 [<a href="#rid7">7</a>]. </p><p class="headingAnchor" id="H3"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span><em>S. moniliformis</em> and <em>S. notomytis</em> can be grown in culture, although they are difficult to grow. By contrast, <em>S. minus</em> is unable to be cultured.</p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>S. moniliformis</em></strong> – <em>S. moniliformis</em> is a pleomorphic, fastidious, branching gram-negative bacillus  (<a class="graphic graphic_picture graphicRef53591" href="/z/d/graphic/53591.html" rel="external">picture 1</a>). It stains irregularly and can be mistaken for gram-positive pleomorphic rods. The bacteria are microaerophilic; they require specific media for isolation (10 to 20% serum) and incubation in a 5 to 10% CO<sub>2</sub> environment. Sodium polyanethol sulfonate (SPS), an anticoagulant added to most aerobic blood culture bottles, inhibits growth of <em>S. moniliformis</em>. This limitation may be overcome by inoculating each bottle with 10 mL of blood [<a href="#rid8">8</a>]. Anaerobic culture bottles, resin bead culture systems, and trypticase soy agar and broth may demonstrate growth if they do not contain SPS. </p><p></p><p class="bulletIndent1"><em>S. moniliformis</em> grows slowly. As a result, the clinical microbiology laboratory should be notified if there is clinical suspicion for the disease so that cultures can be held for up to seven days to allow identification. On solid agar plates, pinpoint colonies representing cell wall-defective variants (L-forms) may surround larger gray-white colonies [<a href="#rid9">9</a>]. Inoculation into thioglycolate broth enriched with serum produces growth in typical "puff-ball" or "cotton ball" colonies [<a href="#rid10">10</a>].<em> </em></p><p></p><p class="bulletIndent1"><em>S. moniliformis</em> can be identified by a characteristic fatty acid profile on gas chromatography [<a href="#rid11">11</a>]. In contrast, biochemical testing is often difficult, and results may be inaccurate because of the fastidious nature of the organism. Identification by 16S rDNA sequencing is feasible although this method is specific to the genus (ie, <em>Streptobacillus</em>) and may not distinguish certain rare species such as <em>S. felis</em> and <em>S. hongkongensis</em> [<a href="#rid12">12</a>]. Mass spectrometry-based identification methods have also been used on direct clinical specimens when clinical suspicion is high, bypassing the need for culture [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>S. notomytis</em></strong> – <em>S. notomytis</em> can be grown in culture similar to <em>S. moniliformis</em> and is distinguishable by 16S rDNA sequencing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>S. minus</em></strong> – <em>S. minus</em>, previously known as <em>Spirocheta morsus</em> or <em>Sporozoa muris</em>, is a short, thick, nonmotile gram-negative tightly coiled spiral that has 2 to 6 helical turns spanning 0.2 to 0.5 micrometers. This organism cannot be cultured on synthetic media but may be seen with Giemsa or Wright stain or with dark-field microscopy [<a href="#rid2">2</a>].</p><p></p><p class="headingAnchor" id="H79338844"><span class="h1">TRANSMISSION</span></p><p class="headingAnchor" id="H1381361007"><span class="h2">S. moniliformis</span><span class="headingEndMark"> — </span><em>S. moniliformis</em> is commonly found in the nasal and oropharyngeal flora of rats and probably other rodents. Most rats are asymptomatic; however, on occasion, they may demonstrate signs of disease [<a href="#rid2">2</a>]. The rate of nasopharyngeal carriage of <em>S. moniliformis</em> by rats (even healthy laboratory rats) is quite variable, reportedly being as high as 100 percent [<a href="#rid14">14,15</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contact with infected rat</strong> – Infection with <em>S. moniliformis</em> can result from a bite or scratch from an infected or colonized rat or from handling rats at home or the workplace (eg, laboratories or pet stores). The risk of infection after a rat bite has been reported to be as high as 10 percent [<a href="#rid2">2</a>]. Transmission can also result from oral contact, such as kissing pet rats [<a href="#rid16">16,17</a>]. Approximately 30 percent of patients with rat bite fever do not report having been bitten or scratched [<a href="#rid10">10,15,18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ingestion of food or water </strong>– Infection with <em>S. moniliformis</em> can also occur after ingestion of food or water contaminated with infected rat feces [<a href="#rid19">19,20</a>]. When infection occurs through this route, it is known as "Haverhill Fever"; this was named after an outbreak in 1926 when 86 persons in Haverhill, Massachusetts developed a febrile illness following the consumption of contaminated unpasteurized milk [<a href="#rid20">20,21</a>]. A similar outbreak occurred in 1983 among 304 boarding school children in Chelmsford, England [<a href="#rid22">22</a>].</p><p></p><p class="headingAnchor" id="H1479264938"><span class="h2">S. minus, S. notomytis</span><span class="headingEndMark"> — </span>The modes of transmission of <em>S. minus, S. notomytis,</em> and <em>S. moniliformis</em> are similar; however, infections with <em>S. minus</em> and <em>S. notomytis</em> have not been associated with contaminated food or water. </p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical manifestations of RBF depend on the causative organism (<em>S. moniliformis</em> or <em>S. minus</em>).</p><p class="headingAnchor" id="H2467860439"><span class="h2">S. moniliformis</span><span class="headingEndMark"> — </span>The clinical manifestations of RBF due to <em>S. moniliformis</em> can range from a mild flu-like illness to fulminant sepsis in children and adults [<a href="#rid19">19,23,24</a>]. The mortality rate of RBF is approximately 13 percent in untreated patients [<a href="#rid2">2,19</a>]. </p><p class="headingAnchor" id="H1648712400"><span class="h3">Initial presentation</span><span class="headingEndMark"> — </span>For individuals with infection due to <em>S. moniliformis</em>, the incubation period is typically fewer than seven days following exposure. (See <a class="local">'S. moniliformis'</a> above.) </p><p>Symptoms start abruptly with fever, myalgias, migratory arthralgias, vomiting, pharyngitis, and headache. By the time symptoms develop due to a bite or scratch, the wound has usually resolved and there is no regional adenopathy [<a href="#rid2">2</a>]. Individuals who acquire RBF through ingestion have more severe vomiting and an increased incidence of pharyngitis compared with those who acquire disease through a bite.</p><p>The initial symptoms are frequently followed by a maculopapular rash on the extremities [<a href="#rid19">19,25</a>], which is then followed by polyarthritis in up to 50 percent of patients [<a href="#rid26">26,27</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The rash is typically seen on the extensor surface of the extremities and may involve the palms and soles [<a href="#rid28">28</a>]. Although usually maculopapular, it can be petechial, purpuric, or present with hemorrhagic vesicles. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The arthritis typically involves the knees, followed by ankles, elbows, wrists, shoulders, and hips. The presentation of arthritis can vary, but the majority of cases are polyarticular, and in some, the distribution is asymmetric [<a href="#rid29">29-32</a>].</p><p></p><p>A case series found that only one-third of children presented with the classical triad of fever, rash, and joint involvement; children more commonly presented with only one or two of these features [<a href="#rid32">32</a>]. Although symptoms may resolve spontaneously without antibiotic therapy, in some cases, the fever can have a relapsing course and the arthritis may persist for several years. In a case report of a child with knee swelling, pathogenic bacteria were found to persist in joints for months despite clearance of the organisms from blood and other sites [<a href="#rid13">13</a>]. However, arthritis may also be due to an immune-mediated mechanism rather than actual infection with the organism [<a href="#rid29">29,30</a>].</p><p class="headingAnchor" id="H3253301888"><span class="h3">Complications</span><span class="headingEndMark"> — </span>Endocarditis (including prosthetic valve endocarditis) is the best-described complication of RBF [<a href="#rid33">33-36</a>]. Individuals often have a history of valvular disease, and symptoms are similar to endocarditis due to other causes, including the presence of anemia, Osler nodes, and hepatosplenomegaly. In one case series, the mortality associated with <em>S. moniliformis</em> endocarditis was 53 percent [<a href="#rid33">33</a>]. </p><p>Case reports have also illustrated a variety of other complications. Bacteremia was the most common complication during the Chelmsford and Haverhill outbreaks [<a href="#rid20">20,37</a>]. Other serious complications include meningitis [<a href="#rid24">24,38</a>], myocarditis, pneumonia [<a href="#rid23">23</a>], focal abscesses in the brain, prostate, spleen, liver, or kidney [<a href="#rid9">9</a>], vasculitis [<a href="#rid39">39</a>], septic arthritis [<a href="#rid29">29,30</a>], osteomyelitis [<a href="#rid40">40</a>], hemophagocytic lymphohistiocytosis [<a href="#rid41">41</a>], and multiorgan failure [<a href="#rid19">19,34</a>]. Two cases of fulminant sepsis and death in previously healthy adults were reported in the United States in 2003, one from a rat bite in a pet store and the other most likely from a sick pet rat [<a href="#rid19">19</a>]. </p><p class="headingAnchor" id="H2467860457"><span class="h2">S. minus</span><span class="headingEndMark"> — </span>In contrast to infection with <em>S. moniliformis</em>, RBF caused by <em>S. minus</em> has a longer incubation period (one to three weeks). In addition, the initial wound may reappear at the onset of the systemic illness or persist with edema and ulceration with associated regional adenopathy [<a href="#rid42">42</a>]. Fever, chills, headache, and malaise are common presenting signs, whereas arthritis and myalgia are infrequent. Approximately 50 percent develop a red-brown macular rash [<a href="#rid2">2,43</a>].</p><p class="headingAnchor" id="H2614471674"><span class="h2">S. notomytis</span><span class="headingEndMark"> — </span>Cases of RBF due to <em>S. notomytis</em> have rarely been described. In one report, <em>S. notomytis</em> was reported to cause fever, rash, and polyarthritis in a woman from Japan following a rat bite on her finger [<a href="#rid44">44</a>]. In another report, <em>S. notomytis</em> was found to cause arthritis and meningitis [<a href="#rid38">38</a>]. </p><p class="headingAnchor" id="H79338908"><span class="h2">Laboratory abnormalities</span><span class="headingEndMark"> — </span>There are no specific lab abnormalities in patients with RBF. Moderately elevated white blood cell counts and sedimentation rates have been reported in some patients [<a href="#rid2">2</a>]. </p><p>The findings in the joint fluid can vary. One case report described a four-year-old patient with rat bite fever and polyarticular arthritis in his distal radioulnar and knee joints [<a href="#rid45">45</a>]. Fluid from the distal radioulnar joint had a leukocyte count of only 31/microL, whereas the knee joint had a leukocyte count of 75,250/microL; both specimens were culture positive for <em>S. moniliformis</em>.</p><p class="headingAnchor" id="H6"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>RBF is most commonly diagnosed empirically because growing <em>S. moniliformis</em> or <em>S. notomytis</em> is difficult and <em>S. minus</em> is unable to be cultured. (See <a class="local">'Empiric diagnosis'</a> below.) </p><p>However, analysis of the 16S rDNA gene sequence has been used for diagnosis on appropriate specimens [<a href="#rid18">18,46,47</a>]. (See <a class="local">'Definitive diagnosis'</a> below.)</p><p>Other diagnostic modalities, such as serologic testing, are not available. </p><p class="headingAnchor" id="H79338920"><span class="h2">Empiric diagnosis</span><span class="headingEndMark"> — </span>An empiric diagnosis of RBF is made in the patient with an unexplained febrile illness or sepsis and a history of rat exposure. This is particularly true in patients with a relapsing or intermittent fever pattern, a maculopapular rash, and/or polyarthritis or polyarthralgia (typically involving the knees and ankles).</p><p class="headingAnchor" id="H100365408"><span class="h2">Definitive diagnosis</span><span class="headingEndMark"> — </span>Confirming a diagnosis of RBF is extremely difficult. If <em>S. moniliformis</em> or <em>S. notomytis</em> is felt to be the causative agent:</p><p class="bulletIndent1"><span class="glyph">●</span>Specimens of blood, synovial fluid, or aspirates from abscesses should be inoculated into bacteriologic media without sodium polyanethol sulfonate (SPS), since SPS inhibits the growth of the organism. Although SPS is present in most aerobic blood culture media, it is not present in some anaerobic culture bottles. The microbiology laboratory should be alerted so that specific media and culture conditions can be used to optimize isolation of the organism. (See <a class="local">'Microbiology'</a> above.) </p><p></p><p class="bulletIndent1">Even with appropriate diagnostic testing, synovial fluid cultures can be negative in cases of uncomplicated disease as the etiology of the arthritis may be due to an immune-mediated mechanism rather than actual infection with the organism [<a href="#rid29">29,30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Real time qPCR testing has been developed and can detect Streptobacillus in tissue samples including blood, synovial fluid, and urine with high sensitivity, if the testing is available [<a href="#rid48">48,49</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>16S rDNA testing (if available) on appropriate specimens such as tissue (heart valve, bone) or synovial fluid may be useful for diagnosis of <em>S. moniliformis </em>or <em>S. notomytis</em>. However, the sensitivity and clinical utility of such testing have not been proven. This type of testing is not available on routine blood samples.</p><p></p><p><em>S. minus</em> is unable to be cultured, and a microbiologic diagnosis is made through demonstration of the organisms on examination of blood, exudate, or tissues using Giemsa or Wright stains or darkfield microscopy.</p><p class="headingAnchor" id="H79338890"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis for a patient presenting with some combination of fever, maculopapular rash, and/or polyarthritis is broad and involves a wide variety of infectious organisms. These agents can usually be diagnosed through readily available culture, serologic, and molecular techniques. It is important to obtain a recent travel and/or exposure history to help prioritize the likely infectious organisms. Detailed discussions of how to diagnose these infections are presented separately in appropriate topic reviews.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fever and rash </strong>– A general approach to the patient with fever and rash is discussed separately (see  <a class="medical medical_review" href="/z/d/html/2744.html" rel="external">"Fever and rash in the immunocompetent patient"</a>). However, in the patient presenting with a fever and rash characteristic of RBF, the following alternative infectious organisms should be considered: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Viral </strong>– There are a number of viral etiologies that should be considered in a patient with fever and a maculopapular rash. These principally include enterovirus, measles, parvovirus, HIV, dengue, lymphocytic choriomeningitis virus, and Epstein-Barr virus. Infection with these viruses should be considered in the patient with a history of appropriate activity and/or exposure. As an example, enterovirus infection should be considered in the patient who works with children. These infections are most commonly diagnosed via serology or polymerase chain reaction (PCR) testing. (See  <a class="medical medical_review" href="/z/d/html/2744.html" rel="external">"Fever and rash in the immunocompetent patient", section on 'Epidemiology and etiology'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bacterial</strong> – Bacterial causes presenting with a petechial rash include endocarditis from <em>Staphylococcus aureus</em> or <em>Streptococcus pyogenes</em>, as well as disseminated gonorrhea and meningococcemia. These infections are usually diagnosed via positive blood or fluid cultures. (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/1300.html" rel="external">"Clinical manifestations of meningococcal infection"</a> and  <a class="medical medical_review" href="/z/d/html/15893.html" rel="external">"Clinical manifestations and diagnosis of <i>Neisseria gonorrhoeae </i>infection in adults and adolescents"</a>.)</p><p></p><p class="bulletIndent2">Unlike the rash associated with RBF, patients with typhoid fever due to <em>Salmonella typhi </em>present with faint macules ("rose spots"), and those with toxic shock syndrome due to <em>S. aureus</em> or <em>Streptococcus</em> species infection are more likely to have a diffuse erythroderma. (See  <a class="medical medical_review" href="/z/d/html/3161.html" rel="external">"Staphylococcal toxic shock syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/3162.html" rel="external">"Invasive group A streptococcal infection and toxic shock syndrome: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis", section on 'Other extraintestinal manifestations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Spirochetal </strong>–<strong> </strong>Spirochetal infections presenting as rash can be maculopapular or petechial, as seen in secondary syphilis, leptospirosis, and relapsing fever due to <em>Borrelia recurrentis</em>. (See  <a class="medical medical_review" href="/z/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/5527.html" rel="external">"Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7897.html" rel="external">"Clinical features, diagnosis, and management of relapsing fever"</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other tick-borne illnesses</strong> – Tick-borne pathogens can cause a macular, maculopapular, or petechial rash as seen in infection due to <em>Rickettsia rickettsia</em> (the agent causing Rocky Mountain Spotted fever), <em>Rickettsia typhi </em>(murine typhus), and less commonly, <em>Anaplasma phagocytophilum</em> and <em>Ehrlichia chaffeensis</em>. (See  <a class="medical medical_review" href="/z/d/html/7904.html" rel="external">"Clinical manifestations and diagnosis of Rocky Mountain spotted fever"</a> and  <a class="medical medical_review" href="/z/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Relapsing fever </strong>– For patients presenting with relapsing fever, <em>B. recurrentis</em> and typhoid fever must be considered [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/7897.html" rel="external">"Clinical features, diagnosis, and management of relapsing fever"</a> and  <a class="medical medical_review" href="/z/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Polyarthritis </strong>– Parvovirus and disseminated gonococcal infection are possibilities in patients who present with polyarthritis plus fever and rash. For patients with more localized joint findings, septic arthritis due to staphylococcal and streptococcal species should be considered. (See  <a class="medical medical_review" href="/z/d/html/7666.html" rel="external">"Septic arthritis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/5614.html" rel="external">"Viral arthritis: Causes and approach to evaluation and management"</a>.) </p><p></p><p class="headingAnchor" id="H7"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>The management of patients with RBF includes both local care of the wound in those reporting a bite, as well as appropriate antibiotics for individuals with clinical symptoms. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>There are no prospective trials concerning the treatment of infection due to <em>S. moniliformis</em>. All data regarding treatment are based on anecdotal reports of the treatment of single or small numbers of patients. (See <a class="local">'Antibiotic therapy'</a> below.)</p><p class="headingAnchor" id="H1048994132"><span class="h2">Management of an animal bite</span><span class="headingEndMark"> — </span>Treatment of RBF associated with an animal bite should begin with appropriate management of the bite wound, such as copious irrigation. Patients should also be assessed to see if tetanus or rabies post-exposure is warranted, although rats and other small rodents are rarely infected with rabies. More detailed discussions of the management of animal bites are presented elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7671.html" rel="external">"Animal bites (dogs, cats, and other mammals): Evaluation and management"</a> and  <a class="medical medical_review" href="/z/d/html/8328.html" rel="external">"Indications for post-exposure rabies prophylaxis"</a>.)</p><p class="headingAnchor" id="H1048994210"><span class="h2">Antibiotic therapy</span><span class="headingEndMark"> — </span>Empiric therapy for RBF should be started immediately in patients with a compatible clinical presentation and exposure history. Laboratory confirmation is difficult and may take several days. If the organism is detected, therapy can be modified based upon antimicrobial susceptibility, which can be determined using standard testing (eg, disk diffusion, broth microdilution). (See <a class="local">'Microbiology'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p>In untreated patients, the mortality rate of RBF has been reported to be as high as 13 percent [<a href="#rid2">2,19</a>]. Although some patients may recover spontaneously, lack of effective antibiotic treatment is highly associated with an increased risk of death. </p><p>Given the rarity of the illness, therapy for RBF is mostly guided by case reports and modest clinical experience. Penicillin is the traditional treatment of choice for RBF since most of the published experience has been with the use of this agent. However, in the absence of clear evidence to the contrary, many experts prefer <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> when intravenous (IV) therapy is indicated since it appears to be effective in treating RBF in case reports [<a href="#rid41">41,50</a>], is effective in treating other known serious penicillin-susceptible infections, and is more easily administered. </p><p>The dose and duration of antibiotic therapy for RBF depend upon the clinical presentation (uncomplicated versus serious invasive disease). (See <a class="local">'Uncomplicated disease'</a> below and <a class="local">'Serious invasive infections'</a> below.)</p><p class="headingAnchor" id="H8"><span class="h3">Uncomplicated disease</span><span class="headingEndMark"> — </span>Cases of RBF typically present as uncomplicated disease, which consists of fever, myalgias, polyarthritis, polyarthralgias, vomiting, headache, and/or rash. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>In most patients with uncomplicated disease we initiate IV therapy and then transition to oral treatment after five to seven days. However, given the possibility that a patient can develop serious invasive disease, the response to treatment must be carefully assessed, and more aggressive treatment (eg, higher or prolonged doses of IV antibiotics) should be considered in those who do not show clinical improvement or if there is concern for complicated disease. (See <a class="local">'Serious invasive infections'</a> below.)</p><p class="headingAnchor" id="H9"><span class="h4">Adults</span><span class="headingEndMark"> — </span>The preferred agents for initial therapy of uncomplicated disease in adults are penicillin or <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a>. </p><p class="bulletIndent1"><span class="glyph">●</span>If IV <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> is initiated, case reports suggest a low dose (1.2 million units per day divided in six equally divided doses) is sufficient for treatment of uncomplicated disease [<a href="#rid2">2,51</a>]. However, if there is uncertainty about the severity of disease, clinicians may prefer to initiate a higher dose (eg, 12 to 18 million units per day in four or six equally divided doses), prior to transitioning to the oral regimen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> is used, a dose of 1 g once daily is reasonable, although there are no data to guide dosing for uncomplicated disease. </p><p></p><p>If the patient has improved clinically after five to seven days, the patient can be transitioned to oral <a class="drug drug_general" data-topicid="9751" href="/z/d/drug information/9751.html" rel="external">penicillin V</a> (500 mg four times per day), <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">ampicillin</a> (500 mg four times per day), or <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">amoxicillin</a> (500 mg three times per day) to complete a 14-day course of therapy. For those who are allergic to penicillin but can tolerate cephalosporins, <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">cephalexin</a> is an alternative. In one case report, oral cephalexin (1 g three times daily) was used to treat osteomyelitis due to <em>S. moniliformis</em> [<a href="#rid52">52</a>].</p><p>In nonpregnant adults who are allergic to penicillin and cephalosporins, <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (100 mg orally or IV twice per day) can be used. The decision to use doxycycline during pregnancy must be decided on a case-by-case basis. Although most tetracyclines are contraindicated in pregnancy because of the risk of hepatotoxicity in the mother and adverse effects on fetal bone and teeth [<a href="#rid53">53-55</a>], these events are rare with short courses of doxycycline. (See  <a class="medical medical_review" href="/z/d/html/494.html" rel="external">"Tetracyclines", section on 'Pregnant or breastfeeding women'</a> and  <a class="medical medical_review" href="/z/d/html/112420.html" rel="external">"Prenatal care: Patient education, health promotion, and safety of commonly used drugs", section on 'Antibiotics'</a>.)</p><p><a class="drug drug_general" data-topicid="10238" href="/z/d/drug information/10238.html" rel="external">Streptomycin</a> and <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">gentamicin</a> are also alternative agents; however, their use is limited because other treatment options with less toxicity are available.</p><p class="headingAnchor" id="H10"><span class="h4">Children</span><span class="headingEndMark"> — </span>For children, initial treatment options typically include IV <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> (100,000 to 150,000 units per kg per day divided in four doses, maximum 8 million units per day) or <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> (50 mg/kg once daily, maximum 2 g/day). Similar to adults, IV therapy is usually administered for five to seven days. Patients who have improved clinically can be transitioned to oral <a class="drug drug_general" data-topicid="9751" href="/z/d/drug information/9751.html" rel="external">penicillin V</a> (25 to 50 mg/kg per day orally in three or four divided doses, maximum 2 g per day) to complete a 14-day course. For those who are allergic to penicillin but can tolerate cephalosporins, oral <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">cephalexin</a> can be used (eg, 50 mg/kg/day divided every eight hours), although there is no published experience to support a specific dose.</p><p>For children who are allergic to penicillin and cephalosporins, we administer a 14-day course of <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a>. Although tetracyclines can cause dental staining when administered to children, the risk of dental staining with doxycycline is minimal if a short course is administered. Children weighing more than 45 kg should receive the adult dose; smaller children should receive 2 to 4 mg/kg per day IV or orally in two divided doses (maximum 200 mg per day).</p><p class="headingAnchor" id="H1048993869"><span class="h3">Serious invasive infections</span><span class="headingEndMark"> — </span>Serious invasive infections complicating RBF are rare. These include endocarditis (including prosthetic valve endocarditis), meningitis, myocarditis, pneumonia, focal abscesses, bacteremia, pyogenic arthritis, and multiple organ failure. Although death has been reported in up to approximately 50 percent, the majority of these occurred in the absence of effective antimicrobial therapy [<a href="#rid2">2,33</a>].</p><p>IV <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> and <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> are the preferred agents. The optimal dose of these agents is unclear, as there are no adequately controlled clinical trials. We favor giving doses adequate to treat other serious penicillin-susceptible infections (eg, streptococcal endocarditis). </p><p>For patients with native valve endocarditis, we administer either IV <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> or <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> for four weeks:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>IV </strong><a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> – For adults, the dosing of IV penicillin G is 12 to 18 million units per day either continuously or in four or six equally divided doses. For individuals whose isolate is not highly susceptible to penicillin (minimum inhibitory concentration [MIC] &gt;0.1 mcg/mL), the dose can be increased to 24 million units per day. </p><p></p><p class="bulletIndent1">For children, the dosing of IV <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> is 200,000 to 300,000 units per kg per day divided in four doses (maximum of 24 million units per day).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">Ceftriaxone</a><strong> </strong>– For adults, the dose of IV ceftriaxone is 2 g once daily. In children, the dose is 100 mg/kg divided every 12 hours (maximum 2 g/dose). </p><p></p><p>For patients with prosthetic valve involvement, an aminoglycoside should be considered, similar to the management of prosthetic valve endocarditis due to other streptococcal species [<a href="#rid2">2,56</a>]. In addition, if <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> is used, we prefer the higher dose (eg, 24 million units per day in adults). More detailed recommendations for dosing in adults and children with prosthetic valve endocarditis are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis", section on 'Streptococci'</a>.)</p><p>For other conditions, the dose and duration may need to be further modified. As an example, for adults with meningitis, the dose of IV <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> should be 2 g twice daily. In those with osteomyelitis, the 2 g daily dose can be used, but the duration may need to be extended. (See  <a class="medical medical_review" href="/z/d/html/114350.html" rel="external">"Nonvertebral osteomyelitis in adults: Treatment", section on 'Duration of therapy'</a>.)</p><p>In both adults and children with complicated disease who are allergic to penicillin and cephalosporins, desensitization to a beta-lactam is generally preferred (see  <a class="medical medical_review" href="/z/d/html/2073.html" rel="external">"Penicillin allergy: Immediate reactions"</a>). If this is not possible, treatment decisions should be made in conjunction with an infectious diseases specialist. </p><p class="headingAnchor" id="H11"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>In persons who have exposure to rats, preventing severe RBF involves increasing their awareness of the signs and symptoms of the infection. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>In addition, following a rat bite, we suggest a three-day course of oral <a class="drug drug_general" data-topicid="9751" href="/z/d/drug information/9751.html" rel="external">penicillin V</a> (adults: 500 mg four times per day; children: 25 to 50 mg/kg per day in three or four divided doses, maximum 2 g per day). <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">Doxycycline</a> is a reasonable alternative. However, the efficacy of antimicrobial prophylaxis is unknown. A more general discussion of antimicrobial therapy after an animal bite is presented separately. (See  <a class="medical medical_review" href="/z/d/html/7671.html" rel="external">"Animal bites (dogs, cats, and other mammals): Evaluation and management", section on 'Bites from mammals other than dogs and cats'</a>.)</p><p>Other measures to limit the incidence of RBF include eradication of rats in urban areas, avoidance of unpasteurized milk and potentially contaminated water, and the use of gloves by laboratory workers when handling rodents or cleaning rat cages. Individuals with pet rats should not kiss or lick them, and they should wash their hands after handling the animals.</p><p class="headingAnchor" id="H14277368"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Rat bite fever (RBF) is a rarely diagnosed, systemic illness caused by infection with <em>Streptobacillus moniliformis, Streptobacillus notomytis,</em> or <em>Spirillum minus</em>. <em>S. moniliformis</em> causes most cases of the disease in the United States. <em>S. minus</em> causes RBF primarily in Asia, although it is probably present worldwide. Infection<em> with S. notomytis</em> has only rarely been reported. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – <em>S. moniliformis</em> is a pleomorphic, fastidious, branching gram-negative bacillus  (<a class="graphic graphic_picture graphicRef53591" href="/z/d/graphic/53591.html" rel="external">picture 1</a>); <em>S. notomytis</em> is similar. Both require specific media for isolation and must be incubated in a 5 to 10% CO<sub>2</sub> environment. <em>S. minus</em> is a tightly coiled spiral, gram-negative rod. It can be identified by darkfield examination but cannot be cultured on artificial media. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission</strong> – Infection with <em>S. moniliformis, S. notomytis,</em> or <em>S. minus</em> can result from a bite or scratch from an infected or colonized rat, or from handling rats at home or the workplace (eg, laboratories or pet stores). Infection with <em>S. moniliformis</em> can also occur after ingestion of food or water contaminated with infected rat feces. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong><em>S. moniliformis </em></strong><strong>or</strong><strong><em> S. notomytis</em></strong><em> </em>– For individuals with infection due to <em>S. moniliformis </em>or<em> S. notomytis</em>, symptoms start abruptly with fever, myalgias, migratory arthralgias, vomiting, pharyngitis, and headache. The incubation period is typically fewer than seven days following exposure. By the time symptoms develop due to a bite or scratch, the wound has usually resolved and there is no regional adenopathy. (See <a class="local">'S. moniliformis'</a> above and <a class="local">'S. notomytis'</a> above.) </p><p></p><p class="bulletIndent2">A variety of complications of RBF due to these organisms have also been reported, including meningitis, endocarditis, and bacteremia. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong><em>S. minus</em></strong> – Infection with <em>S. minus</em> has a longer incubation period (one to three weeks) and is characterized by fever, chills, headache, and malaise. In addition, the initial wound may reappear at the onset of the systemic illness or persist with edema and ulceration with associated regional adenopathy. (See <a class="local">'S. minus'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – RBF is most commonly diagnosed clinically because growing <em>S. moniliformis</em> is difficult and no serologic test is available. However, culture yield may be improved if grown in culture bottles without sodium polyanethol sulfonate (eg, certain anerobic culture bottles); in addition, analysis of the 16S rDNA gene sequence has been used for diagnosis on appropriate specimens. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of infection</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Local wound care</strong> – The management of patients with RBF includes local care of the wound in those reporting a bite and antibiotics. The need for tetanus and/or <a class="drug drug_general" data-topicid="9850" href="/z/d/drug information/9850.html" rel="external">rabies vaccine</a> should also be assessed. (See <a class="local">'Management of an animal bite'</a> above and <a class="local">'Antibiotic therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antimicrobial therapy</strong> – Patients with suspected RBF require immediate antibiotic treatment to reduce the mortality associated with this infection. Empiric therapy should be initiated in patients with a compatible clinical presentation and exposure history since laboratory confirmation is difficult and may take several days. (See <a class="local">'Treatment'</a> above.) </p><p></p><p class="bulletIndent2">For most patients, we suggest initial therapy with intravenous (IV) <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> or <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). The dose and duration depend upon the clinical presentation (uncomplicated versus serious invasive therapy). </p><p></p><p class="bulletIndent2">For those with uncomplicated disease, IV therapy is typically administered for five to seven days. Patients who have improved clinically can be transitioned to oral therapy to complete a 14-day course. By contrast, for those with serious invasive disease (eg, endocarditis), higher doses of IV therapy are administered for an extended duration (eg, four weeks). (See <a class="local">'Antibiotic therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preventive therapy</strong> – To prevent infection following a rat bite, we suggest a three-day course of oral <a class="drug drug_general" data-topicid="9751" href="/z/d/drug information/9751.html" rel="external">penicillin V</a> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). For adults, we administer 500 mg four times per day; for children, the dose is 25 to 50 mg/kg per day in three or four divided doses (maximum 2 g per day). However, the efficacy of antimicrobial prophylaxis is unknown. (See <a class="local">'Prevention'</a> above.) </p><p></p><p><strong>ACKNOWLEDGMENT</strong> — The UpToDate editorial staff acknowledges Michele Trucksis, PhD, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Adam JK, Varan AK, Pong AL, et al. Notes from the field: fatal rat-bite fever in a child - San Diego County, California, 2013. MMWR Morb Mortal Wkly Rep 2014; 63:1210.</a></li><li><a class="nounderline abstract_t">Elliott SP. Rat bite fever and Streptobacillus moniliformis. Clin Microbiol Rev 2007; 20:13.</a></li><li><a class="nounderline abstract_t">Hirschhorn RB, Hodge RR. Identification of risk factors in rat bite incidents involving humans. Pediatrics 1999; 104:e35.</a></li><li><a class="nounderline abstract_t">Khatchadourian K, Ovetchkine P, Minodier P, et al. The rise of the rats: A growing paediatric issue. Paediatr Child Health 2010; 15:131.</a></li><li><a class="nounderline abstract_t">Crews JD, Palazzi DL, Starke JR. A teenager with fever, rash, and arthralgia. Streptobacillus moniliformis infection. JAMA Pediatr 2014; 168:1165.</a></li><li><a class="nounderline abstract_t">Kache PA, Person MK, Seeman SM, et al. Rat-Bite Fever in the United States: An Analysis Using Multiple National Data Sources, 2001-2015. Open Forum Infect Dis 2020; 7:ofaa197.</a></li><li><a class="nounderline abstract_t">Eisenberg T, Glaeser SP, Ewers C, et al. Streptobacillus notomytis sp. nov., isolated from a  spinifex hopping mouse (Notomys alexis Thomas,  1922), and emended description of Streptobacillus  Levaditi et al. 1925, Eisenberg et al. 2015 emend. Int J Syst Evol Microbiol 2015; 65:4823.</a></li><li><a class="nounderline abstract_t">Szewc AM, Bell ME, Kelly AJ, et al. Using the BDFX40 Automated Continuous Blood Culture System to Isolate and Recover Streptobacillus moniliformis in the Presence of 0.05% SPS: A 55-Year, 56-Strain Retrospective Study. Lab Med 2021; 52:536.</a></li><li><a class="nounderline abstract_t">Pins MR, Holden JM, Yang JM, et al. Isolation of presumptive Streptobacillus moniliformis from abscesses associated with the female genital tract. Clin Infect Dis 1996; 22:471.</a></li><li><a class="nounderline abstract_t">Torres L, López AI, Escobar S, et al. Bacteremia by Streptobacillus moniliformis: first case described in Spain. Eur J Clin Microbiol Infect Dis 2003; 22:258.</a></li><li><a class="nounderline abstract_t">Rowbotham TJ. Rapid identification of Streptobacillus moniliformis. Lancet 1983; 2:567.</a></li><li><a class="nounderline abstract_t">Eisenberg T, Nicklas W, Mauder N, et al. Phenotypic and Genotypic Characteristics of Members of the Genus Streptobacillus. PLoS One 2015; 10:e0134312.</a></li><li><a class="nounderline abstract_t">Mackey JR, Melendez EL, Farrell JJ, et al. Direct detection of indirect transmission of Streptobacillus moniliformis rat bite fever infection. J Clin Microbiol 2014; 52:2259.</a></li><li><a class="nounderline abstract_t">Anderson LC, Leary SL, Manning PJ. Rat-bite fever in animal research laboratory personnel. Lab Anim Sci 1983; 33:292.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Rat-bite fever--New Mexico, 1996. MMWR Morb Mortal Wkly Rep 1998; 47:89.</a></li><li><a class="nounderline abstract_t">Miraflor AP, Davallow Ghajar L, Subramaniam S, et al. Rat-bite fever: An uncommon cause of fever and rash in a 9-year-old patient. JAAD Case Rep 2015; 1:371.</a></li><li><a class="nounderline abstract_t">Vetter NM, Feder HM Jr, Ratzan RM. Rat bite fever caused by a kiss. Am J Emerg Med 2016; 34:1190.e3.</a></li><li><a class="nounderline abstract_t">Nei T, Sato A, Sonobe K, et al. Streptobacillus moniliformis bacteremia in a rheumatoid arthritis patient without a rat bite: a case report. BMC Res Notes 2015; 8:694.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Fatal rat-bite fever--Florida and Washington, 2003. MMWR Morb Mortal Wkly Rep 2005; 53:1198.</a></li><li><a class="nounderline abstract_t">Place, EH, Sutton, LE Jr. Erythema athriticum epidemicum (Haverhill fever). Arch Intern Med 1934; 54:659.</a></li><li><a class="nounderline abstract_t">Parker F, Hudson NP. The Etiology of Haverhill Fever (Erythema Arthriticum Epidemicum). Am J Pathol 1926; 2:357.</a></li><li><a class="nounderline abstract_t">McEvoy MB, Noah ND, Pilsworth R. Outbreak of fever caused by Streptobacillus moniliformis. Lancet 1987; 2:1361.</a></li><li><a class="nounderline abstract_t">McHugh TP, Bartlett RL, Raymond JI. Rat bite fever: report of a fatal case. Ann Emerg Med 1985; 14:1116.</a></li><li><a class="nounderline abstract_t">Sens MA, Brown EW, Wilson LR, Crocker TP. Fatal Streptobacillus moniliformis infection in a two-month-old infant. Am J Clin Pathol 1989; 91:612.</a></li><li><a class="nounderline abstract_t">Giorgiutti S, Lefebvre N. Rat Bite Fever. N Engl J Med 2019; 381:1762.</a></li><li><a class="nounderline abstract_t">Stehle P, Dubuis O, So A, Dudler J. Rat bite fever without fever. Ann Rheum Dis 2003; 62:894.</a></li><li><a class="nounderline abstract_t">Mandel DR. Streptobacillary fever. An unusual cause of infectious arthritis. Cleve Clin Q 1985; 52:203.</a></li><li><a class="nounderline abstract_t">Tandon R, Lee M, Curran E, et al. A 26-year-old woman with a rash on her extremities. Clin Infect Dis 2006; 43:1585.</a></li><li><a class="nounderline abstract_t">Dendle C, Woolley IJ, Korman TM. Rat-bite fever septic arthritis: illustrative case and literature review. Eur J Clin Microbiol Infect Dis 2006; 25:791.</a></li><li><a class="nounderline abstract_t">Wang TK, Wong SS. Streptobacillus moniliformis septic arthritis: a clinical entity distinct from rat-bite fever? BMC Infect Dis 2007; 7:56.</a></li><li><a class="nounderline abstract_t">Pirogard N, Arromdee E, Muangsomboon S, Rattanaumpawan P. Rat bite fever caused by Streptobacillus notomytis mimicking pyogenic polyarthritis: A case report. IDCases 2023; 34:e01923.</a></li><li><a class="nounderline abstract_t">Hadvani T, Vallejo JG, Dutta A. Rat Bite Fever: Variability in Clinical Presentation and Management in Children. Pediatr Infect Dis J 2021; 40:e439.</a></li><li><a class="nounderline abstract_t">Rupp ME. Streptobacillus moniliformis endocarditis: case report and review. Clin Infect Dis 1992; 14:769.</a></li><li><a class="nounderline abstract_t">Shvartsblat S, Kochie M, Harber P, Howard J. Fatal rat bite fever in a pet shop employee. Am J Ind Med 2004; 45:357.</a></li><li><a class="nounderline abstract_t">Rordorf T, Züger C, Zbinden R, et al. Streptobacillus moniliformis endocarditis in an HIV-positive patient. Infection 2000; 28:393.</a></li><li><a class="nounderline abstract_t">Chen PL, Lee NY, Yan JJ, et al. Prosthetic valve endocarditis caused by Streptobacillus moniliformis: a case of rat bite fever. J Clin Microbiol 2007; 45:3125.</a></li><li><a class="nounderline abstract_t">Shanson DC, Gazzard BG, Midgley J, et al. Streptobacillus moniliformis isolated from blood in four cases of Haverhill fever. Lancet 1983; 2:92.</a></li><li><a class="nounderline abstract_t">Pongsuttiyakorn S, Kamolvit W, Limsrivanichakorn S, et al. Rat bite fever due to Streptobacillus notomytis complicated by meningitis and spondylodiscitis: a case report. BMC Infect Dis 2021; 21:1017.</a></li><li><a class="nounderline abstract_t">Błaż A, Zalewski J, Masiak A, et al. Rat bite fever mimicking ANCA-associated vasculitis. Rheumatol Int 2023; 43:1957.</a></li><li><a class="nounderline abstract_t">Pena E, Jordão S, Simões MJ, et al. A rare cause of vertebral osteomyelitis: the first case report of rat-bite fever in Portugal. Rev Soc Bras Med Trop 2019; 53:e20190328.</a></li><li><a class="nounderline abstract_t">Heaton P, Schultz NH, Helseth PH, et al. Streptobacillus moniliformis With Features of Hemophagocytic Lymphohistiocytosis Identified by Direct Sequencing. Pediatr Infect Dis J 2020; 39:1131.</a></li><li class="breakAll">http://www.cdc.gov/rat-bite-fever/health-care-workers/index.html#diagnosis (Accessed on September 23, 2013).</li><li><a class="nounderline abstract_t">Gaastra W, Boot R, Ho HT, Lipman LJ. Rat bite fever. Vet Microbiol 2009; 133:211.</a></li><li><a class="nounderline abstract_t">Fukushima K, Yanagisawa N, Imaoka K, et al. Rat-bite fever due to Streptobacillus notomytis isolated from a human specimen. J Infect Chemother 2018; 24:302.</a></li><li><a class="nounderline abstract_t">Wegner AM, Look N, Haus BM. Surgical Management of Multijoint Septic Arthritis due to Rat-Bite Fever in a Pediatric Patient: A Case Study. Case Rep Orthop 2017; 2017:2183941.</a></li><li><a class="nounderline abstract_t">Kondruweit M, Weyand M, Mahmoud FO, et al. Fulminant endocarditis caused by Streptobacillus moniliformis in a young man. J Thorac Cardiovasc Surg 2007; 134:1579.</a></li><li><a class="nounderline abstract_t">Eisenberg T, Ewers C, Rau J, et al. Approved and novel strategies in diagnostics of rat bite fever and other Streptobacillus infections in humans and animals. Virulence 2016; 7:630.</a></li><li><a class="nounderline abstract_t">Fawzy A, Giel AS, Fenske L, et al. Development and validation of a triplex real-time qPCR for sensitive detection and quantification of major rat bite fever pathogen Streptobacillus moniliformis. J Microbiol Methods 2022; 199:106525.</a></li><li><a class="nounderline abstract_t">Kelly AJ, Ivey ML, Gulvik CA, et al. A real-time multiplex PCR assay for detection of the causative agents of rat bite fever, Streptobacillus moniliformis and zoonoticStreptobacillus species. Diagn Microbiol Infect Dis 2021; 100:115335.</a></li><li><a class="nounderline abstract_t">Matthews C, Ausman S. Rat-bite fever: Taking the bite out of a textbook case of Streptobacillus moniliformis blood stream infection. IDCases 2021; 25:e01199.</a></li><li><a class="nounderline abstract_t">ROUGHGARDEN JW. ANTIMICROBIAL THERAPY OF RATBITE FEVER. A REVIEW. Arch Intern Med 1965; 116:39.</a></li><li><a class="nounderline abstract_t">Adams SH, Mahapatra R. Rat bite fever with osteomyelitis and discitis: case report and literature review. BMC Infect Dis 2021; 21:479.</a></li><li><a class="nounderline abstract_t">Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55:1.</a></li><li><a class="nounderline abstract_t">Vennila V, Madhu V, Rajesh R, et al. Tetracycline-induced discoloration of deciduous teeth: case series. J Int Oral Health 2014; 6:115.</a></li><li><a class="nounderline abstract_t">Cohlan SQ, Bevelander G, Tiamsic T. Growth Inhibition of Prematures Receiving Tetracycline. Am J Dis Child 1963; 105:453.</a></li><li><a class="nounderline abstract_t">McCormack RC, Kaye D, Hook EW. Endocarditis due to streptobacillus moniliformis. JAMA 1967; 200:77.</a></li></ol></div><div id="topicVersionRevision">Topic 5528 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25522092" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Notes from the field: fatal rat-bite fever in a child - San Diego County, California, 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17223620" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Rat bite fever and Streptobacillus moniliformis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10469818" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Identification of risk factors in rat bite incidents involving humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21358889" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The rise of the rats: A growing paediatric issue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25436846" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A teenager with fever, rash, and arthralgia. Streptobacillus moniliformis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32617373" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Rat-Bite Fever in the United States: An Analysis Using Multiple National Data Sources, 2001-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26438009" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Streptobacillus notomytis sp. nov., isolated from a  spinifex hopping mouse (Notomys alexis Thomas,  1922), and emended description of Streptobacillus  Levaditi et al. 1925, Eisenberg et al. 2015 emend.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33693831" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Using the BDFX40 Automated Continuous Blood Culture System to Isolate and Recover Streptobacillus moniliformis in the Presence of 0.05% SPS: A 55-Year, 56-Strain Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8852965" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Isolation of presumptive Streptobacillus moniliformis from abscesses associated with the female genital tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12709841" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Bacteremia by Streptobacillus moniliformis: first case described in Spain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6136713" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Rapid identification of Streptobacillus moniliformis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26252790" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Phenotypic and Genotypic Characteristics of Members of the Genus Streptobacillus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24719439" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Direct detection of indirect transmission of Streptobacillus moniliformis rat bite fever infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6876736" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Rat-bite fever in animal research laboratory personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9480409" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Rat-bite fever--New Mexico, 1996.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27051784" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Rat-bite fever: An uncommon cause of fever and rash in a 9-year-old patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26698680" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Rat bite fever caused by a kiss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26584844" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Streptobacillus moniliformis bacteremia in a rheumatoid arthritis patient without a rat bite: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15635289" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Fatal rat-bite fever--Florida and Washington, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Erythema athriticum epidemicum (Haverhill fever)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19969709" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The Etiology of Haverhill Fever (Erythema Arthriticum Epidemicum).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2890953" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Outbreak of fever caused by Streptobacillus moniliformis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4051282" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Rat bite fever: report of a fatal case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2718962" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Fatal Streptobacillus moniliformis infection in a two-month-old infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31665580" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Rat Bite Fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12922966" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Rat bite fever without fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4028420" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Streptobacillary fever. An unusual cause of infectious arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17109293" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A 26-year-old woman with a rash on her extremities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17096137" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Rat-bite fever septic arthritis: illustrative case and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17561996" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Streptobacillus moniliformis septic arthritis: a clinical entity distinct from rat-bite fever?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37965383" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Rat bite fever caused by Streptobacillus notomytis mimicking pyogenic polyarthritis: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34260491" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Rat Bite Fever: Variability in Clinical Presentation and Management in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1562665" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Streptobacillus moniliformis endocarditis: case report and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15029568" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Fatal rat bite fever in a pet shop employee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11139161" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Streptobacillus moniliformis endocarditis in an HIV-positive patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17652475" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Prosthetic valve endocarditis caused by Streptobacillus moniliformis: a case of rat bite fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6134972" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Streptobacillus moniliformis isolated from blood in four cases of Haverhill fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34583654" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Rat bite fever due to Streptobacillus notomytis complicated by meningitis and spondylodiscitis: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37450033" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Rat bite fever mimicking ANCA-associated vasculitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31859955" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A rare cause of vertebral osteomyelitis: the first case report of rat-bite fever in Portugal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32868746" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Streptobacillus moniliformis With Features of Hemophagocytic Lymphohistiocytosis Identified by Direct Sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32868746" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Streptobacillus moniliformis With Features of Hemophagocytic Lymphohistiocytosis Identified by Direct Sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19008054" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Rat bite fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29191371" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Rat-bite fever due to Streptobacillus notomytis isolated from a human specimen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28255484" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Surgical Management of Multijoint Septic Arthritis due to Rat-Bite Fever in a Pediatric Patient: A Case Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18023687" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Fulminant endocarditis caused by Streptobacillus moniliformis in a young man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27088660" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Approved and novel strategies in diagnostics of rat bite fever and other Streptobacillus infections in humans and animals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35738493" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Development and validation of a triplex real-time qPCR for sensitive detection and quantification of major rat bite fever pathogen Streptobacillus moniliformis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33618204" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A real-time multiplex PCR assay for detection of the causative agents of rat bite fever, Streptobacillus moniliformis and zoonoticStreptobacillus species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34189044" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Rat-bite fever: Taking the bite out of a textbook case of Streptobacillus moniliformis blood stream infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14338952" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : ANTIMICROBIAL THERAPY OF RATBITE FEVER. A REVIEW.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34039283" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Rat bite fever with osteomyelitis and discitis: case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16572105" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25083046" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Tetracycline-induced discoloration of deciduous teeth: case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Growth Inhibition of Prematures Receiving Tetracycline</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6071862" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Endocarditis due to streptobacillus moniliformis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
